210 related articles for article (PubMed ID: 27256357)
1. Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.
Masaki C; Sharpley AL; Cooper CM; Godlewska BR; Singh N; Vasudevan SR; Harmer CJ; Churchill GC; Sharp T; Rogers RD; Cowen PJ
Psychopharmacology (Berl); 2016 Jul; 233(14):2655-61. PubMed ID: 27256357
[TBL] [Abstract][Full Text] [Related]
2. The putative lithium-mimetic ebselen reduces impulsivity in rodent models.
Barkus C; Ferland JN; Adams WK; Churchill GC; Cowen PJ; Bannerman DM; Rogers RD; Winstanley CA; Sharp T
J Psychopharmacol; 2018 Sep; 32(9):1018-1026. PubMed ID: 29986609
[TBL] [Abstract][Full Text] [Related]
3. Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.
Masaki C; Sharpley AL; Godlewska BR; Berrington A; Hashimoto T; Singh N; Vasudevan SR; Emir UE; Churchill GC; Cowen PJ
Psychopharmacology (Berl); 2016 Mar; 233(6):1097-104. PubMed ID: 26758281
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.
Singh N; Sharpley AL; Emir UE; Masaki C; Herzallah MM; Gluck MA; Sharp T; Harmer CJ; Vasudevan SR; Cowen PJ; Churchill GC
Neuropsychopharmacology; 2016 Jun; 41(7):1768-78. PubMed ID: 26593266
[TBL] [Abstract][Full Text] [Related]
5. Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication.
Ramli FF; Singh N; Emir UE; Villa LM; Waters S; Harmer CJ; Cowen PJ; Godlewska BR
Transl Psychiatry; 2024 May; 14(1):200. PubMed ID: 38714646
[TBL] [Abstract][Full Text] [Related]
6. Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
Singh N; Serres F; Toker L; Sade Y; Blackburn V; Batra AS; Saiardi A; Agam G; Belmaker RH; Sharp T; Vasudevan SR; Churchill GC
Eur J Pharmacol; 2020 Sep; 883():173377. PubMed ID: 32687920
[TBL] [Abstract][Full Text] [Related]
7. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
Sharpley AL; Williams C; Holder AA; Godlewska BR; Singh N; Shanyinde M; MacDonald O; Cowen PJ
Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
[TBL] [Abstract][Full Text] [Related]
8. A safe lithium mimetic for bipolar disorder.
Singh N; Halliday AC; Thomas JM; Kuznetsova OV; Baldwin R; Woon EC; Aley PK; Antoniadou I; Sharp T; Vasudevan SR; Churchill GC
Nat Commun; 2013; 4():1332. PubMed ID: 23299882
[TBL] [Abstract][Full Text] [Related]
9. Ebselen has lithium-like effects on central 5-HT
Antoniadou I; Kouskou M; Arsiwala T; Singh N; Vasudevan SR; Fowler T; Cadirci E; Churchill GC; Sharp T
Br J Pharmacol; 2018 Jul; 175(13):2599-2610. PubMed ID: 29488218
[TBL] [Abstract][Full Text] [Related]
10. The Potential Use of Ebselen in Treatment-Resistant Depression.
Ramli FF; Cowen PJ; Godlewska BR
Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455482
[TBL] [Abstract][Full Text] [Related]
11. Lithium Pharmacogenetics: Where Do We Stand?
Pisanu C; Melis C; Squassina A
Drug Dev Res; 2016 Nov; 77(7):368-373. PubMed ID: 27633500
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and structure of ebselen bound to Cys141 of human inositol monophosphatase.
Fenn GD; Waller-Evans H; Atack JR; Bax BD
Acta Crystallogr F Struct Biol Commun; 2020 Oct; 76(Pt 10):469-476. PubMed ID: 33006574
[TBL] [Abstract][Full Text] [Related]
13. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation.
Santi C; Scimmi C; Sancineto L
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299505
[TBL] [Abstract][Full Text] [Related]
14. Structural and biochemical analysis of human inositol monophosphatase-1 inhibition by ebselen.
Abuhammad A; Laurieri N; Rice A; Lowe ED; Singh N; Naser SM; Ratrout SS; Churchill GC
J Biomol Struct Dyn; 2023; 41(23):14036-14048. PubMed ID: 36762717
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and Anti-neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration.
Landgraf AD; Alsegiani AS; Alaqel S; Thanna S; Shah ZA; Sucheck SJ
ACS Chem Neurosci; 2020 Oct; 11(19):3008-3016. PubMed ID: 32840996
[TBL] [Abstract][Full Text] [Related]
16. Early effects of mirtazapine on emotional processing.
Arnone D; Horder J; Cowen PJ; Harmer CJ
Psychopharmacology (Berl); 2009 May; 203(4):685-91. PubMed ID: 19031070
[TBL] [Abstract][Full Text] [Related]
17. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
18. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons.
Xu JH; Hu HT; Liu Y; Qian YH; Liu ZH; Tan QR; Zhang ZJ
Neurosci Lett; 2006 May; 399(3):210-4. PubMed ID: 16513270
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of ebselen on experimental spinal cord injury in rats.
Kalayci M; Coskun O; Cagavi F; Kanter M; Armutcu F; Gul S; Acikgoz B
Neurochem Res; 2005 Mar; 30(3):403-10. PubMed ID: 16018585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]